메뉴 건너뛰기




Volumn , Issue , 2009, Pages 151-185

Pharmacokinetics and pharmacodynamics of drugs abused in driving

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84879905231     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7643-9923-8_11     Document Type: Chapter
Times cited : (4)

References (142)
  • 2
    • 28044457038 scopus 로고    scopus 로고
    • Human cannabinoid pharmacokinetics and interpretation of cannabinoid concentrations in biological fluids and tissues
    • MA ElSohly ed:, Humana Press, Totawa, New Jersey
    • Huestis MA, Smith ML (2006) Human cannabinoid pharmacokinetics and interpretation of cannabinoid concentrations in biological fluids and tissues. In: MA ElSohly (ed): Marijuana and the Cannabinoids. Humana Press, Totawa, New Jersey, 205-236
    • (2006) Marijuana and the Cannabinoids , pp. 205-236
    • Huestis, M.A.1    Smith, M.L.2
  • 4
  • 5
    • 3743113111 scopus 로고
    • An historical survey of alcohol, drugs and traffic safety - Research highlights
    • PC Noordzij, R Roszbach, JJ de Gier, W Neuteboom, PGM Zweipfenning eds:, Excerpta Medica, Amsterdam
    • Borkenstein RF (1987) An historical survey of alcohol, drugs and traffic safety - research highlights. In: PC Noordzij, R Roszbach, JJ de Gier, W Neuteboom, PGM Zweipfenning (eds): Alcohol, Drugs and Traffic Safety - T 86. Excerpta Medica, Amsterdam, 51-60
    • (1987) Alcohol, Drugs and Traffic Safety - T 86 , pp. 51-60
    • Borkenstein, R.F.1
  • 6
    • 0026736782 scopus 로고
    • Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THCCOOH)
    • Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta- 9-tetrahydrocannabinol (THCCOOH). J Anal Toxicol 16:283-290
    • (1992) J Anal Toxicol , vol.16 , pp. 283-290
    • Huestis, M.A.1    Henningfield, J.E.2    Cone, E.J.3
  • 7
    • 28044456281 scopus 로고    scopus 로고
    • Estimating the time of last cannabis use from plasma delta9- tetrahydrocannabinol and ll-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations
    • Huestis MA, Barnes A, Smith ML (2005) Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and ll-nor-9-carboxy- delta9-tetrahydrocannabinol concentrations. Clin Chem 51:2289-2295
    • (2005) Clin Chem , vol.51 , pp. 2289-2295
    • Huestis, M.A.1    Barnes, A.2    Smith, M.L.3
  • 8
  • 11
    • 34548510337 scopus 로고    scopus 로고
    • Human cannabinoid pharmacokinetics
    • Huestis MA (2007) Human cannabinoid pharmacokinetics. Chem Biodivers 4:1770-1804
    • (2007) Chem Biodivers , vol.4 , pp. 1770-1804
    • Huestis, M.A.1
  • 14
    • 0026701051 scopus 로고
    • Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana
    • Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276-282
    • (1992) J Anal Toxicol , vol.16 , pp. 276-282
    • Huestis, M.A.1    Henningfield, J.E.2    Cone, E.J.3
  • 15
    • 33645754286 scopus 로고    scopus 로고
    • Pharmacokinetics and metabolism of the plant cannabinoids, delta-9-tetrahydrocannabinol, cannabidiol and cannabinol
    • RG Pertwee ed:, Springer, New York
    • Huestis MA (2005) Pharmacokinetics and metabolism of the plant cannabinoids, delta-9-tetrahydrocannabinol, cannabidiol and cannabinol. In: RG Pertwee (ed): Handbook of Experimental Pharmacology, Volume 168. Springer, New York, 657-690
    • (2005) Handbook of Experimental Pharmacology , vol.168 , pp. 657-690
    • Huestis, M.A.1
  • 16
    • 0019308268 scopus 로고
    • Constituents of cannabis sativa L. XVII. A review of the natural constituents
    • Turner CE, El Sohly MA, Boeren EG (1980) Constituents of cannabis sativa L. XVII. a review of the natural constituents. J Nat Prod 43:169-234
    • (1980) J Nat Prod , vol.43 , pp. 169-234
    • Turner, C.E.1    El Sohly, M.A.2    Boeren, E.G.3
  • 17
    • 0014234790 scopus 로고
    • Uber das Verhalten von Hanf und von delta-9-6a, lOa- transtetrahydrocannabinol beim Rauchen
    • Claussen U, Korte F (1968) Uber das Verhalten von Hanf und von delta-9-6a, lOa-transtetrahydrocannabinol beim Rauchen. Justus Liebigs. Ann. Chem. 713:162-165
    • (1968) Justus Liebigs. Ann. Chem. , vol.713 , pp. 162-165
    • Claussen, U.1    Korte, F.2
  • 18
    • 27844450586 scopus 로고
    • Constituents of cannabis sativa L. XXIV: Cannabitetrol, a new polyhydroxylated cannabinoid
    • S Agurell, WL Dewey, RE Willette eds:, Academic Press, Inc., Orlando
    • El Sohly HN, Boeren EG, Turner CE, El Sohly MA (1984) Constituents of cannabis sativa L. XXIV: Cannabitetrol, a new polyhydroxylated cannabinoid. In: S Agurell, WL Dewey, RE Willette (eds): The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects. Academic Press, Inc., Orlando, 89-96
    • (1984) The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects , pp. 89-96
    • El Sohly, H.N.1    Boeren, E.G.2    Turner, C.E.3    El Sohly, M.A.4
  • 20
    • 0014933381 scopus 로고
    • Marihuana chemistry
    • Mechoulam R (1970) Marihuana chemistry. Science 168:1159-1166
    • (1970) Science , vol.168 , pp. 1159-1166
    • Mechoulam, R.1
  • 21
    • 0018963804 scopus 로고
    • Plasma delta-9-tetrahydrocamiabinol concentrations and clinical effects after oral and intravenous administration and smoking
    • Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1980) Plasma delta-9-tetrahydrocamiabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28:409-416
    • (1980) Clin Pharmacol Ther , vol.28 , pp. 409-416
    • Ohlsson, A.1    Lindgren, J.E.2    Wahlen, A.3    Agurell, S.4    Hollister, L.E.5    Gillespie, H.K.6
  • 22
    • 0015117546 scopus 로고
    • Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking
    • Agurell S, Leander K (1971) Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking. Acta Pharm Suec 8:391-402
    • (1971) Acta Pharm Suec , vol.8 , pp. 391-402
    • Agurell, S.1    Leander, K.2
  • 26
    • 0026665588 scopus 로고
    • Marijuana smoking: Effect of varying delta 9-tetrahydrocannabinol content and number of puffs
    • Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM (1992) Marijuana smoking: Effect of varying delta 9-tetrahydrocannabinol content and number of puffs. J Pharmacol Exp Ther 261(1):114-122
    • (1992) J Pharmacol Exp Ther , vol.261 , Issue.1 , pp. 114-122
    • Azorlosa, J.L.1    Heishman, S.J.2    Stitzer, M.L.3    Mahaffey, J.M.4
  • 27
    • 0024408790 scopus 로고
    • Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance
    • Heishman SJ, Stitzer ML, Yingling JE (1989) Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav 34:173-179
    • (1989) Pharmacol Biochem Behav , vol.34 , pp. 173-179
    • Heishman, S.J.1    Stitzer, M.L.2    Yingling, J.E.3
  • 28
    • 0025571462 scopus 로고
    • Marijuana smoking: Factors that influence the bioavailability of tetrahydrocannabinol
    • CN Chiang, RL Hawks eds:, NIDA Research Monograph #99, Rockville
    • Perez-Reyes M (1990) Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol. In: CN Chiang, RL Hawks (eds): Research Findings on Smoking of Abused Substances. NIDA Research Monograph #99, Rockville, 42-62
    • (1990) Research Findings on Smoking of Abused Substances , pp. 42-62
    • Perez-Reyes, M.1
  • 29
    • 0025955818 scopus 로고
    • Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes
    • Cami J, Guerra D, Ugena B, Segura J, De La Torre R (1991) Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes. Pharmacol Biochem Behav 40:115-119
    • (1991) Pharmacol Biochem Behav , vol.40 , pp. 115-119
    • Cami, J.1    Guerra, D.2    Ugena, B.3    Segura, J.4    De La Torre, R.5
  • 30
    • 0019606080 scopus 로고
    • The clinical pharmacology and dynamics of marijuana cigarette smoking
    • Perez-Reyes M, Owens SM, Di Guiseppi S (1981) The clinical pharmacology and dynamics of marijuana cigarette smoking. J Clin Pharmacol 21:201S-207S
    • (1981) J Clin Pharmacol , vol.21
    • Perez-Reyes, M.1    Owens, S.M.2    Di Guiseppi, S.3
  • 31
    • 0030902952 scopus 로고    scopus 로고
    • Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana
    • Harder S, Rietbrock S (1997) Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana. Int J Clin Pharmacol Ther 35:155-159
    • (1997) Int J Clin Pharmacol Ther , vol.35 , pp. 155-159
    • Harder, S.1    Rietbrock, S.2
  • 32
    • 0021240213 scopus 로고
    • Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin
    • Law B, Mason PA, Moffat AC, Gleadle RI, King LJ (1984) Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. J Pharm Pharmacol 36:289-294
    • (1984) J Pharm Pharmacol , vol.36 , pp. 289-294
    • Law, B.1    Mason, P.A.2    Moffat, A.C.3    Gleadle, R.I.4    King, L.J.5
  • 35
    • 0020565632 scopus 로고
    • Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women
    • Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34:352-363
    • (1983) Clin Pharmacol Ther , vol.34 , pp. 352-363
    • Wall, M.E.1    Sadler, B.M.2    Brine, D.3    Taylor, H.4    Perez-Reyes, M.5
  • 36
    • 29144518601 scopus 로고    scopus 로고
    • Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract
    • Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F (2005) Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract. J Anal Toxicol 29:782-789
    • (2005) J Anal Toxicol , vol.29 , pp. 782-789
    • Nadulski, T.1    Sporkert, F.2    Schnelle, M.3    Stadelmann, A.M.4    Roser, P.5    Schefter, T.6    Pragst, F.7
  • 37
    • 0016766526 scopus 로고
    • Psychosis following ingestion of hemp in children
    • Binitie A (1975) Psychosis following ingestion of hemp in children. Psychopharmacologia 44:301-302
    • (1975) Psychopharmacologia , vol.44 , pp. 301-302
    • Binitie, A.1
  • 38
  • 39
    • 33746814904 scopus 로고    scopus 로고
    • Delta (9)-tetrahydrocannabinol, ll-hydroxy-delta (9)-tetrahydrocannabinol and ll-nor-9-carboxy-delta (9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids
    • Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA (2006) Delta (9)-tetrahydrocannabinol, ll-hydroxy-delta (9)-tetrahydrocannabinol and ll-nor-9-carboxy-delta (9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids. Ther Drug Monit 28:545-551
    • (2006) Ther Drug Monit , vol.28 , pp. 545-551
    • Goodwin, R.S.1    Gustafson, R.A.2    Barnes, A.3    Nebro, W.4    Moolchan, E.T.5    Huestis, M.A.6
  • 40
    • 0014954447 scopus 로고
    • Marihuana: Studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man
    • Lemberger L, Silberstein SD, Axelrod J, Kopin IJ (1970) Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man. Science 170:1320-1322
    • (1970) Science , vol.170 , pp. 1320-1322
    • Lemberger, L.1    Silberstein, S.D.2    Axelrod, J.3    Kopin, I.J.4
  • 41
    • 0029830331 scopus 로고    scopus 로고
    • Cannabis: Pharmacology and toxicology in animals and humans
    • Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91(11):1585-1614
    • (1996) Addiction , vol.91 , Issue.11 , pp. 1585-1614
    • Adams, I.B.1    Martin, B.R.2
  • 42
  • 43
    • 0015514995 scopus 로고
    • Intravenous injection in man of delta-9-tetrahydrocannabinol and ll-OH-delta-9-tetrahydrocannabinol
    • Perez-Reyes M, Timmons MC, Lipton MA, Davis KH, Wall ME (1972) Intravenous injection in man of delta-9-tetrahydrocannabinol and ll-OH-delta-9-tetrahydrocannabinol. Science 111:633-635
    • (1972) Science , vol.111 , pp. 633-635
    • Perez-Reyes, M.1    Timmons, M.C.2    Lipton, M.A.3    Davis, K.H.4    Wall, M.E.5
  • 44
    • 0019292856 scopus 로고
    • Tolerance and disposition of tetrahydrocannabinol in man
    • Hunt CA, Jones RT (1980) Tolerance and disposition of tetrahydrocannabinol in man. J Pharmacol Exp Ther 215:35-44
    • (1980) J Pharmacol Exp Ther , vol.215 , pp. 35-44
    • Hunt, C.A.1    Jones, R.T.2
  • 45
    • 0026764602 scopus 로고
    • Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users
    • Kelly P, Jones RT (1992) Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J Anal Toxicol 16:228-235
    • (1992) J Anal Toxicol , vol.16 , pp. 228-235
    • Kelly, P.1    Jones, R.T.2
  • 46
    • 0037255987 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of cannabinoids
    • Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327-360
    • (2003) Clin Pharmacokinet , vol.42 , pp. 327-360
    • Grotenhermen, F.1
  • 47
    • 0002851561 scopus 로고    scopus 로고
    • Absorption, distribution, and biotransformation of the cannabinoids
    • GG Nahas, KM Sutin, DJ Harvey, S Agurell eds:, Humana Press, Totowa
    • Harvey DJ (2001) Absorption, distribution, and biotransformation of the cannabinoids. In: GG Nahas, KM Sutin, DJ Harvey, S Agurell (eds): Marijuana and Medicine. Humana Press, Totowa, 91-103
    • (2001) Marijuana and Medicine , pp. 91-103
    • Harvey, D.J.1
  • 48
    • 0024575997 scopus 로고
    • Determination of delta-1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry
    • Johansson E, Noren K, Sjovall J, Halldin MM (1989) Determination of delta-1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry. Biomed Chromatogr 3:35-38
    • (1989) Biomed Chromatogr , vol.3 , pp. 35-38
    • Johansson, E.1    Noren, K.2    Sjovall, J.3    Halldin, M.M.4
  • 49
    • 37049245573 scopus 로고
    • Delta-9-tetrahydrocannabinol: Localization in body fat
    • Kreuz DS, Axelrod J (1973) Delta-9-tetrahydrocannabinol: Localization in body fat. Science 179:391-393
    • (1973) Science , vol.179 , pp. 391-393
    • Kreuz, D.S.1    Axelrod, J.2
  • 50
    • 0017367380 scopus 로고
    • Pharmacokinetics of delta-9-tetrahydrocannabinol in dogs
    • Garrett ER, Hunt CA (1977) Pharmacokinetics of delta-9- tetrahydrocannabinol in dogs. J Pharm Sci 66:395-406
    • (1977) J Pharm Sci , vol.66 , pp. 395-406
    • Garrett, E.R.1    Hunt, C.A.2
  • 51
    • 0015583214 scopus 로고
    • Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3-H-delta-9-tetrahydrocannabinol
    • Dewey WL, McMillan DE, Harris LS, Turk RF (1972) Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3-H-delta-9-tetrahydrocannabinol. Biochemical Pharmacology 22:399-405
    • (1972) Biochemical Pharmacology , vol.22 , pp. 399-405
    • Dewey, W.L.1    McMillan, D.E.2    Harris, L.S.3    Turk, R.F.4
  • 52
    • 0029014012 scopus 로고
    • Metabolism of delta-9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys
    • Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H (1995) Metabolism of delta-9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys. Life Sci 56:2089-2095
    • (1995) Life Sci , vol.56 , pp. 2089-2095
    • Matsunaga, T.1    Iwawaki, Y.2    Watanabe, K.3    Yamamoto, I.4    Kageyama, T.5    Yoshimura, H.6
  • 54
    • 0026586613 scopus 로고
    • Human hepatic microsomal metabolism of delta-1-tetrahydrocannabinol
    • Bornheim LM, Lasker JM, Raucy JL (1992) Human hepatic microsomal metabolism of delta-1-tetrahydrocannabinol. Drug Metab Dispos 20(2):241-246
    • (1992) Drug Metab Dispos , vol.20 , Issue.2 , pp. 241-246
    • Bornheim, L.M.1    Lasker, J.M.2    Raucy, J.L.3
  • 55
    • 0022885683 scopus 로고
    • GC/MS and Emit analyses for delta-9-tetrah-drocannabinol metabolites in plasma and urine of human subjects
    • McBurney LJ, Bobbie BA, Sepp LA (1986) GC/MS and Emit analyses for delta-9-tetrah-drocannabinol metabolites in plasma and urine of human subjects. J Anal Toxicol 10:5664
    • (1986) J Anal Toxicol , vol.10 , pp. 5664
    • McBurney, L.J.1    Bobbie, B.A.2    Sepp, L.A.3
  • 57
    • 0019946170 scopus 로고
    • Identification of in vitro metabolites of delta-tetrahydrocannabinol formed by human livers
    • Halldin MM, Widman M, Bahr CV, Lindgren JE, Martin BR (1982) Identification of in vitro metabolites of delta-tetrahydrocannabinol formed by human livers. Drug Metab Dispos 10:297-301
    • (1982) Drug Metab Dispos , vol.10 , pp. 297-301
    • Halldin, M.M.1    Widman, M.2    Bahr, C.V.3    Lindgren, J.E.4    Martin, B.R.5
  • 58
    • 0021832353 scopus 로고
    • Cannabis: Pharmacology and interpretation of effects
    • Mason AP, McBay AJ (1985) Cannabis: Pharmacology and interpretation of effects. J Forensic Sci 30:615-631
    • (1985) J Forensic Sci , vol.30 , pp. 615-631
    • Mason, A.P.1    McBay, A.J.2
  • 59
    • 0015208116 scopus 로고
    • Delta-9-tetrahydrocannabinol: Metabolism and disposition in long-term marihuana smokers
    • Lemberger L, Tamarkin NR, Axelrod J (1971) Delta-9-tetrahydrocannabinol: metabolism and disposition in long-term marihuana smokers. Science 173:72-74
    • (1971) Science , vol.173 , pp. 72-74
    • Lemberger, L.1    Tamarkin, N.R.2    Axelrod, J.3
  • 60
    • 0019147162 scopus 로고
    • Identification in human urine of delta-9-tetrahydrocannabinol-11-oic glucuronide: A tetrahydrocannabinol metabolite
    • Williams PL, Moffat AC (1980) Identification in human urine of delta-9-tetrahydrocannabinol-11-oic glucuronide: a tetrahydrocannabinol metabolite. J Pharm Pharmacol 32:445-448
    • (1980) J Pharm Pharmacol , vol.32 , pp. 445-448
    • Williams, P.L.1    Moffat, A.C.2
  • 62
    • 0029112885 scopus 로고
    • Cannabinoids in humans. I. Analysis of delta-9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS
    • Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA (1995) Cannabinoids in humans. I. Analysis of delta-9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J Anal Toxicol 19:285-291
    • (1995) J Anal Toxicol , vol.19 , pp. 285-291
    • Kemp, P.M.1    Abukhalaf, I.K.2    Manno, J.E.3    Manno, B.R.4    Alford, D.D.5    Abusada, G.A.6
  • 63
    • 0023917930 scopus 로고
    • Prolonged apparent half-life of delta-1-tetrahydrocannabinol in plasma of chronic marijuana users
    • Johansson E, Agurell S, Hollister LE, Halldin MM (1988) Prolonged apparent half-life of delta-1-tetrahydrocannabinol in plasma of chronic marijuana users. J Pharm Pharmacol 40:374-375
    • (1988) J Pharm Pharmacol , vol.40 , pp. 374-375
    • Johansson, E.1    Agurell, S.2    Hollister, L.E.3    Halldin, M.M.4
  • 64
    • 0024440522 scopus 로고
    • Terminal elimination plasma half-life of delta-1-tetrahydrocannabinol (delta-1-THC) in heavy users of marijuana
    • Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK (1989) Terminal elimination plasma half-life of delta-1-tetrahydrocannabinol (delta-1-THC) in heavy users of marijuana. Eur J Clin Pharmacol 37:273-277
    • (1989) Eur J Clin Pharmacol , vol.37 , pp. 273-277
    • Johansson, E.1    Halldin, M.M.2    Agurell, S.3    Hollister, L.E.4    Gillespie, H.K.5
  • 65
    • 0024324572 scopus 로고
    • Urinary excretion half-life of deltal-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking
    • Johansson E, Halldin MM (1989) Urinary excretion half-life of deltal-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking. J Anal Toxicol 13:218-223
    • (1989) J Anal Toxicol , vol.13 , pp. 218-223
    • Johansson, E.1    Halldin, M.M.2
  • 66
    • 0029793333 scopus 로고    scopus 로고
    • Urinary excretion profiles of 1 l-nor-9-carboxydelta9- tetrahydrocannabinol in humans after single smoked doses of marijuana
    • Huestis MA, Mitchell JM, Cone EJ (1996) Urinary excretion profiles of 1 l-nor-9-carboxydelta9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol 20:441-452
    • (1996) J Anal Toxicol , vol.20 , pp. 441-452
    • Huestis, M.A.1    Mitchell, J.M.2    Cone, E.J.3
  • 67
    • 0019417069 scopus 로고
    • Clinical effects and plasma levels of delta-9-tetrahydrocannabinol (delta-9-THC) in heavy and light users of cannabis
    • Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H (1981) Clinical effects and plasma levels of delta-9-tetrahydrocannabinol (delta-9-THC) in heavy and light users of cannabis. Psychopharmacology 74:208-212
    • (1981) Psychopharmacology , vol.74 , pp. 208-212
    • Lindgren, J.E.1    Ohlsson, A.2    Agurell, S.3    Hollister, L.4    Gillespie, H.5
  • 68
    • 0019605560 scopus 로고
    • The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man
    • Wall ME, Perez-Reyes M (1981) The metabolism of delta-9- tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 21:178S-189S
    • (1981) J Clin Pharmacol , vol.21
    • Wall, M.E.1    Perez-Reyes, M.2
  • 69
    • 0242471883 scopus 로고
    • Distribution of delta-9-tetrahydrocannabinol and its metabolites
    • RC Baselt ed:, Year Book Medical Publishers, Chicago
    • Peat MA (1989) Distribution of delta-9-tetrahydrocannabinol and its metabolites. In: RC Baselt (ed): Advances in Analytical Toxicology II. Year Book Medical Publishers, Chicago, 186-217
    • (1989) Advances in Analytical Toxicology II , pp. 186-217
    • Peat, M.A.1
  • 71
    • 34547828152 scopus 로고    scopus 로고
    • Simultaneous quantification of delta-9-tetrahydrocannabinol (THC), 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC), and ll-nor-delta-9- tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry
    • Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA (2007) Simultaneous quantification of delta-9-tetrahydrocannabinol (THC), 11-hydroxy-delta-9-tetrahydrocannabinol (11-OH-THC), and ll-nor-delta-9- tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 1163:318-327
    • (2007) J Chromatogr A , vol.1163 , pp. 318-327
    • Lowe, R.H.1    Karschner, E.L.2    Schwilke, E.W.3    Barnes, A.J.4    Huestis, M.A.5
  • 72
    • 4344654745 scopus 로고    scopus 로고
    • Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis
    • Huestis MA, Cone EJ (2004) Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 28:394-399
    • (2004) J Anal Toxicol , vol.28 , pp. 394-399
    • Huestis, M.A.1    Cone, E.J.2
  • 73
    • 0012894895 scopus 로고    scopus 로고
    • Ministerium für Wirtschaft Mittelstand, Technologie und Verkehr NRWAbschlussberichtZ. B. 3.4721:03-02/93
    • Daldrup T (1996) Cannabis im Strassenverkehr. Ministerium für Wirtschaft Mittelstand, Technologie und Verkehr NRWAbschlussberichtZ. B. 3.4721:03-02/93
    • (1996) Cannabis im Strassenverkehr
    • Daldrup, T.1
  • 74
    • 0042564601 scopus 로고    scopus 로고
    • Absolute Fahmntiichtigkeit unter der Wirkung von Cannabis - Vorschlag fur einen Granzwert
    • Drasch G, Von Meyer L, Roider G (2003) Absolute Fahmntiichtigkeit unter der Wirkung von Cannabis - Vorschlag fur einen Granzwert. Blutalkohol 40:269-286
    • (2003) Blutalkohol , vol.40 , pp. 269-286
    • Drasch, G.1    Von Meyer, L.2    Roider, G.3
  • 75
    • 33748157825 scopus 로고    scopus 로고
    • Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use
    • Musshoff F, Madea B (2006) Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 28:155-163
    • (2006) Ther Drug Monit , vol.28 , pp. 155-163
    • Musshoff, F.1    Madea, B.2
  • 77
    • 0028284551 scopus 로고
    • Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance
    • Chait LD, Perry JL (1994) Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 115:340-349
    • (1994) Psychopharmacology , vol.115 , pp. 340-349
    • Chait, L.D.1    Perry, J.L.2
  • 79
    • 0015443052 scopus 로고
    • Effect of marijuana on the visual autokinetic phenomenon
    • Sharma S, Moskowitz H (1972) Effect of marijuana on the visual autokinetic phenomenon. Percept Mot Skills 35:891-894
    • (1972) Percept Mot Skills , vol.35 , pp. 891-894
    • Sharma, S.1    Moskowitz, H.2
  • 83
    • 0025666791 scopus 로고
    • Acute and residual effects of marijuana: Profiles of plasma THC levels, physiological, subjective, and performance measures
    • Heishman SJ, Huestis MA, Henningfield JE, Cone EJ (1990) Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav 37:561-565
    • (1990) Pharmacol Biochem Behav , vol.37 , pp. 561-565
    • Heishman, S.J.1    Huestis, M.A.2    Henningfield, J.E.3    Cone, E.J.4
  • 85
    • 0037868745 scopus 로고    scopus 로고
    • Cannabis (Marijuana) - Effects on human behavior and performance
    • LJ Farrell, BK Logan, KM Dubowski eds:, Central Police University Press, Taipei
    • Huestis MA (2002) Cannabis (Marijuana) - Effects on Human Behavior and Performance. In: LJ Farrell, BK Logan, KM Dubowski (eds): The Effects of Drugs on Human Performance and Behavior. Central Police University Press, Taipei, 15-60
    • (2002) The Effects of Drugs on Human Performance and Behavior , pp. 15-60
    • Huestis, M.A.1
  • 87
    • 0036303941 scopus 로고    scopus 로고
    • Effects of concurrent use of alcohol and cocaine
    • Pennings EJ, Leccese AP, Wolff FA (2002) Effects of concurrent use of alcohol and cocaine. Addiction 97:773-783
    • (2002) Addiction , vol.97 , pp. 773-783
    • Pennings, E.J.1    Leccese, A.P.2    Wolff, F.A.3
  • 89
    • 0029145959 scopus 로고
    • Pharmacokinetics and pharmacodynamics of cocaine
    • Cone EJ (1995) Pharmacokinetics and pharmacodynamics of cocaine. J Anal Toxicol 19:459-478
    • (1995) J Anal Toxicol , vol.19 , pp. 459-478
    • Cone, E.J.1
  • 90
    • 33750183625 scopus 로고    scopus 로고
    • Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration
    • Kolbrich E, Barnes A, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA (2006) Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol 30:501-510
    • (2006) J Anal Toxicol , vol.30 , pp. 501-510
    • Kolbrich, E.1    Barnes, A.2    Gorelick, D.A.3    Boyd, S.J.4    Cone, E.J.5    Huestis, M.A.6
  • 91
    • 0017256760 scopus 로고
    • Cocaine: Plasma concentrations after intranasal application in man
    • Van Dyke C, Barash PG, Jatlow P, Byck R (1976) Cocaine: plasma concentrations after intranasal application in man. Science 191:859-861
    • (1976) Science , vol.191 , pp. 859-861
    • Van Dyke, C.1    Barash, P.G.2    Jatlow, P.3    Byck, R.4
  • 92
    • 0018160396 scopus 로고
    • Cocaine plasma concentration: Relation to physiological and subjective effects in humans
    • Javaid JI, Fischman MW, Schuster CR, Dekirmenjian H, Davis JM (1978) Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 202:227-228
    • (1978) Science , vol.202 , pp. 227-228
    • Javaid, J.I.1    Fischman, M.W.2    Schuster, C.R.3    Dekirmenjian, H.4    Davis, J.M.5
  • 93
    • 0020048605 scopus 로고
    • Plasma cocaine concentrations during cocaine paste smoking
    • Paly D, Jatlow P, Van Dyke C, Jeri FR, Byck R (1982) Plasma cocaine concentrations during cocaine paste smoking. Life Sci 30:731-738
    • (1982) Life Sci , vol.30 , pp. 731-738
    • Paly, D.1    Jatlow, P.2    Van Dyke, C.3    Jeri, F.R.4    Byck, R.5
  • 94
    • 0033815631 scopus 로고    scopus 로고
    • Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers
    • Jufer RA, Wstadik A, Walsh SL, Levine BS, Cone EJ (2000) Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol 24:467-477
    • (2000) J Anal Toxicol , vol.24 , pp. 467-477
    • Jufer, R.A.1    Wstadik, A.2    Walsh, S.L.3    Levine, B.S.4    Cone, E.J.5
  • 95
    • 0033809703 scopus 로고    scopus 로고
    • Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: Plasma and saliva analysis
    • Moolchan ET, Cone EJ, Wstadik A, Huestis MA, Preston KL (2000) Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. J Anal Toxicol 24:458-466
    • (2000) J Anal Toxicol , vol.24 , pp. 458-466
    • Moolchan, E.T.1    Cone, E.J.2    Wstadik, A.3    Huestis, M.A.4    Preston, K.L.5
  • 96
    • 0024512439 scopus 로고
    • Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking
    • Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE (1989) Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 17:153-159
    • (1989) Drug Metab Dispos , vol.17 , pp. 153-159
    • Jeffcoat, A.R.1    Perez-Reyes, M.2    Hill, J.M.3    Sadler, B.M.4    Cook, C.E.5
  • 97
    • 84882372668 scopus 로고    scopus 로고
    • Cocaine
    • B Levine ed:, AACC Press, Washington
    • Isenschmid D (2006) Cocaine. In: B Levine (ed): Principles of Forensic Toxicology. AACC Press, Washington, 239-260
    • (2006) Principles of Forensic Toxicology , pp. 239-260
    • Isenschmid, D.1
  • 98
    • 0035093516 scopus 로고    scopus 로고
    • Cocaine, ethanol, and cocaethylene cardiotoxity in an animal model of cocaine and ethanol abuse
    • Wilson LD, Jeromin J, Garvey L, Dorbandt A (2001) Cocaine, ethanol, and cocaethylene cardiotoxity in an animal model of cocaine and ethanol abuse. Acad Emerg Med 8:211-222
    • (2001) Acad Emerg Med , vol.8 , pp. 211-222
    • Wilson, L.D.1    Jeromin, J.2    Garvey, L.3    Dorbandt, A.4
  • 100
    • 0028132050 scopus 로고
    • Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine
    • Perez-Reyes M, Jeffcoat AR, Myers M, Sihler K, Cook CE (1994) Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. Psychopharmacology 116:428-432
    • (1994) Psychopharmacology , vol.116 , pp. 428-432
    • Perez-Reyes, M.1    Jeffcoat, A.R.2    Myers, M.3    Sihler, K.4    Cook, C.E.5
  • 101
    • 84900612399 scopus 로고
    • Stability of drugs of abuse in biological specimens
    • R Lui, Goldberger, BA ed:, AACC Press, Washington
    • Levine B, Smith ML (1995) Stability of Drugs of Abuse in Biological Specimens. In: R Lui, Goldberger, BA (ed): Handbook of Workplace Drug Testing. AACC Press, Washington, 209-224
    • (1995) Handbook of Workplace Drug Testing , pp. 209-224
    • Levine, B.1    Smith, M.L.2
  • 106
    • 0027190508 scopus 로고
    • Treatment of narcolepsy with methamphetamine
    • Mitler MM, Hajdukovic R, Erman MK (1993) Treatment of narcolepsy with methamphetamine. Sleep 16:306-317
    • (1993) Sleep , vol.16 , pp. 306-317
    • Mitler, M.M.1    Hajdukovic, R.2    Erman, M.K.3
  • 108
    • 0037232980 scopus 로고    scopus 로고
    • Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers
    • Schepers RJF, Oyler JM, Joseph RE, Jr., Cone EJ, Moolchan ET, Huestis MA (2003) Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 49:121-132
    • (2003) Clin Chem , vol.49 , pp. 121-132
    • Schepers, R.J.F.1    Oyler, J.M.2    Joseph Jr., R.E.3    Cone, E.J.4    Moolchan, E.T.5    Huestis, M.A.6
  • 109
    • 0029885150 scopus 로고    scopus 로고
    • Methamphetamine and driving impairment
    • Logan BK (1996) Methamphetamine and driving impairment. J Forensic Sci 41:457-464
    • (1996) J Forensic Sci , vol.41 , pp. 457-464
    • Logan, B.K.1
  • 111
    • 34250378668 scopus 로고    scopus 로고
    • Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: Lack of association with clinical evidence of impairment
    • Jones AW (2007) Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment. Addiction 102:1085-1091
    • (2007) Addiction , vol.102 , pp. 1085-1091
    • Jones, A.W.1
  • 112
    • 0029144375 scopus 로고
    • Driving ability in cancer patients receiving long-term morphine analgesia
    • Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E (1995) Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 346:667-670
    • (1995) Lancet , vol.346 , pp. 667-670
    • Vainio, A.1    Ollila, J.2    Matikainen, E.3    Rosenberg, P.4    Kalso, E.5
  • 115
    • 0028866159 scopus 로고
    • A review of the effects of opioids on psychomotor and cognitive functioning in humans
    • Zacny JP (1995) A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 3:432-466
    • (1995) Exp Clin Psychopharmacol , vol.3 , pp. 432-466
    • Zacny, J.P.1
  • 116
    • 0025755623 scopus 로고
    • Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients - A comparison of two oral formulations
    • Hasselstrom J, Alexander N, Bringel C, Svensson JO, Sawe J (1991) Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients - a comparison of two oral formulations. Eur J Clin Pharmacol 40:585-591
    • (1991) Eur J Clin Pharmacol , vol.40 , pp. 585-591
    • Hasselstrom, J.1    Alexander, N.2    Bringel, C.3    Svensson, J.O.4    Sawe, J.5
  • 117
    • 0030946338 scopus 로고    scopus 로고
    • Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration
    • Skopp G, Ganssmann B, Cone EJ, Aderjan R (1997) Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration. J Anal Toxicol 21:105-111
    • (1997) J Anal Toxicol , vol.21 , pp. 105-111
    • Skopp, G.1    Ganssmann, B.2    Cone, E.J.3    Aderjan, R.4
  • 118
    • 0033787139 scopus 로고    scopus 로고
    • Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program
    • Gyr E, Brenneisen R, Bourquin D, Lehmann T, Vonlanthen D, Hug I (2000) Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program. Int J Clin Pharmacol Ther 38:486-491
    • (2000) Int J Clin Pharmacol Ther , vol.38 , pp. 486-491
    • Gyr, E.1    Brenneisen, R.2    Bourquin, D.3    Lehmann, T.4    Vonlanthen, D.5    Hug, I.6
  • 119
    • 0034795246 scopus 로고    scopus 로고
    • Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin
    • Smith ML, Shimomura ET, Summers J, Paul BD, Jenkins A J, Darwin WD, Cone E J (2001) Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol 25:504-514
    • (2001) J Anal Toxicol , vol.25 , pp. 504-514
    • Smith, M.L.1    Shimomura, E.T.2    Summers, J.3    Paul, B.D.4    Jenkins, A.J.5    Darwin, W.D.6    Cone, E.J.7
  • 120
    • 0032825034 scopus 로고    scopus 로고
    • Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration
    • O'Neal CL, Crouch D J, Rollins DE, Fatah A, Cheever ML (1999) Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration. J Anal Toxicol 23:452-459
    • (1999) J Anal Toxicol , vol.23 , pp. 452-459
    • O'Neal, C.L.1    Crouch, D.J.2    Rollins, D.E.3    Fatah, A.4    Cheever, M.L.5
  • 122
    • 0025764727 scopus 로고
    • A case of high opiate tolerance: Implications for drug analyses and interpretations
    • Gjerde H, Morland J (1991) A case of high opiate tolerance: implications for drug analyses and interpretations. Int J Legal Med 104:239-240
    • (1991) Int J Legal Med , vol.104 , pp. 239-240
    • Gjerde, H.1    Morland, J.2
  • 124
    • 0021075584 scopus 로고
    • Capillary GLC assay for carbinoxamine and hydrocodone in human serum using nitrogen-sensitive detection
    • Hoffman DJ, Leveque MJ, Thomson T (1983) Capillary GLC assay for carbinoxamine and hydrocodone in human serum using nitrogen-sensitive detection. J Pharm Sci 72:1342-1344
    • (1983) J Pharm Sci , vol.72 , pp. 1342-1344
    • Hoffman, D.J.1    Leveque, M.J.2    Thomson, T.3
  • 126
    • 0030999676 scopus 로고    scopus 로고
    • Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability
    • Kaplan HL, Busto UE, Baylon GJ, Cheung SW, Otton SV, Somer G, Sellers EM (1997) Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. J Pharmacol Exp Ther 281:103-108
    • (1997) J Pharmacol Exp Ther , vol.281 , pp. 103-108
    • Kaplan, H.L.1    Busto, U.E.2    Baylon, G.J.3    Cheung, S.W.4    Otton, S.V.5    Somer, G.6    Sellers, E.M.7
  • 127
    • 0028878658 scopus 로고
    • Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry
    • Smith ML, Hughes RO, Levine B, Dickerson S, Darwin WD, Cone EJ (1995) Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry. J Anal Toxicol 19:18-26
    • (1995) J Anal Toxicol , vol.19 , pp. 18-26
    • Smith, M.L.1    Hughes, R.O.2    Levine, B.3    Dickerson, S.4    Darwin, W.D.5    Cone, E.J.6
  • 128
    • 0019500243 scopus 로고
    • Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects
    • Vallner JJ, Stewart JT, Kotzan JA, Kirsten EB, Honignerg IL (1981) Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol 21:152-156
    • (1981) J Clin Pharmacol , vol.21 , pp. 152-156
    • Vallner, J.J.1    Stewart, J.T.2    Kotzan, J.A.3    Kirsten, E.B.4    Honignerg, I.L.5
  • 129
    • 0028843621 scopus 로고
    • Steady-state pharmacokinetics of hydromorphone and hydromorphone-3- glucuronide in cancer patients after immediate and controlled-release hydromorphone
    • Hagen N, Thirlwell MP, Dhaliwal HS, Babul N, Harsanyi Z, Darke AC (1995) Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. J Clin Pharmacol 35:37-44
    • (1995) J Clin Pharmacol , vol.35 , pp. 37-44
    • Hagen, N.1    Thirlwell, M.P.2    Dhaliwal, H.S.3    Babul, N.4    Harsanyi, Z.5    Darke, A.C.6
  • 130
    • 0033819965 scopus 로고    scopus 로고
    • Identification of hydrocodone in human urine following controlled codeine administration
    • Oyler JM, Cone EJ, Joseph RE, Jr., Huestis MA (2000) Identification of hydrocodone in human urine following controlled codeine administration. J Anal Toxicol 24:530-535
    • (2000) J Anal Toxicol , vol.24 , pp. 530-535
    • Oyler, J.M.1    Cone, E.J.2    Joseph Jr., R.E.3    Huestis, M.A.4
  • 131
    • 33646178983 scopus 로고    scopus 로고
    • Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine
    • Cone EJ, Heit HA, Caplan YH, Gourlay D (2006) Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. J Anal Toxicol 30:1-5
    • (2006) J Anal Toxicol , vol.30 , pp. 1-5
    • Cone, E.J.1    Heit, H.A.2    Caplan, Y.H.3    Gourlay, D.4
  • 133
    • 0018393096 scopus 로고
    • Quantitative GLC determination of oxycodone in human plasma
    • Renzi NL, Jr., Tam JN (1979) Quantitative GLC determination of oxycodone in human plasma. J Pharm Sci 68:43-45
    • (1979) J Pharm Sci , vol.68 , pp. 43-45
    • Renzi Jr., N.L.1    Tam, J.N.2
  • 134
    • 0029853665 scopus 로고    scopus 로고
    • Characterization and validation of a pharmacokinetic model for controlled-release oxycodone
    • Mandema JW, Kaiko RF, Oshlack B, Reder RF, Stanski DR (1996) Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Clin Pharmacol 42:747-756
    • (1996) Br J Clin Pharmacol , vol.42 , pp. 747-756
    • Mandema, J.W.1    Kaiko, R.F.2    Oshlack, B.3    Reder, R.F.4    Stanski, D.R.5
  • 136
    • 0015402416 scopus 로고
    • The levels of methadone in the plasma in methadone maintenance
    • Inturrisi CE, Verebely K (1972) The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther 13:633-637
    • (1972) Clin Pharmacol Ther , vol.13 , pp. 633-637
    • Inturrisi, C.E.1    Verebely, K.2
  • 137
    • 0042934163 scopus 로고    scopus 로고
    • Methadone and metabolite urine concentrations in patients maintained on methadone
    • Preston KL, Epstein DH, Davoudzadeh D, Huestis MA (2003) Methadone and metabolite urine concentrations in patients maintained on methadone. J Anal Toxicol 27:332-341
    • (2003) J Anal Toxicol , vol.27 , pp. 332-341
    • Preston, K.L.1    Epstein, D.H.2    Davoudzadeh, D.3    Huestis, M.A.4
  • 138
    • 34848857532 scopus 로고    scopus 로고
    • Opioids-effects on human performance and behavior
    • Stout PRFL (2003) Opioids-Effects on Human Performance and Behavior. Forensic Sci Rev 15:29-59
    • (2003) Forensic Sci Rev , vol.15 , pp. 29-59
    • Stout, P.R.F.L.1
  • 139
    • 0032436459 scopus 로고    scopus 로고
    • Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
    • Heiskanen T, Olkkola KT, Kalso E (1998) Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacol Ther 64:603-611
    • (1998) Clin Pharmacol Ther , vol.64 , pp. 603-611
    • Heiskanen, T.1    Olkkola, K.T.2    Kalso, E.3
  • 140
    • 34548319334 scopus 로고    scopus 로고
    • Recommendations for toxicological investigation of drug impaired driving
    • Farrell LJ, Kerrigan S, Logan BK (2007) Recommendations for toxicological investigation of drug impaired driving. J Forensic Sci 52:1214-1218
    • (2007) J Forensic Sci , vol.52 , pp. 1214-1218
    • Farrell, L.J.1    Kerrigan, S.2    Logan, B.K.3
  • 142
    • 84900660309 scopus 로고    scopus 로고
    • Developing global strategies for identifying, prosecuting, and treating drug-impaired drivers
    • JM Walsh ed
    • Walsh JM (2004) Developing global strategies for identifying, prosecuting, and treating drug-impaired drivers. In: JM Walsh (ed), Bethesda, 1-58
    • (2004) Bethesda , pp. 1-58
    • Walsh, J.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.